Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Share the Article
Lv SQ. Correction to “Jianpi Gushen Huayu decoction ameliorated diabetic nephropathy through modulating metabolites in kidney, and inhibiting TLR4/NF-κB/NLRP3 and JNK/P38 pathways”. World J Diabetes 2026; 17(4): 119227 [DOI: 10.4239/wjd.v17.i4.119227]
World J Diabetes. Apr 15, 2026; 17(4): 119227 Published online Apr 15, 2026. doi: 10.4239/wjd.v17.i4.119227
Correction to “Jianpi Gushen Huayu decoction ameliorated diabetic nephropathy through modulating metabolites in kidney, and inhibiting TLR4/NF-κB/NLRP3 and JNK/P38 pathways”
Shu-Quan Lv
Shu-Quan Lv, Department of Endocrinology, Cangzhou Hospital of Integrated Traditional Chinese and Western Medicine of Hebei Province Affiliated to Hebei University of Chinese Medicine, Cangzhou 061012, Hebei Province, China
Author contributions: Lv SQ solely contributed to this paper.
Conflict-of-interest statement: The author reports no relevant conflicts of interest for this article.
Corresponding author: Shu-Quan Lv, PhD, Chief Physician, Department of Endocrinology, Cangzhou Hospital of Integrated Traditional Chinese and Western Medicine of Hebei Province Affiliated to Hebei University of Chinese Medicine, No. 5 Xianghai Road, High-tech Zone, Cangzhou 061012, Hebei Province, China. czlvshuquan@163.com
Received: January 23, 2026 Revised: February 4, 2026 Accepted: March 18, 2026 Published online: April 15, 2026 Processing time: 82 Days and 19.8 Hours
Abstract
This is a correction to the published paper titled “Jianpi Gushen Huayu decoction ameliorated diabetic nephropathy through modulating metabolites in kidney, and inhibiting TLR4/NF-κB/NLRP3 and JNK/P38 pathways”. Figure 2 is incorrect as it appears in the published version. This correction is requested to ensure the accuracy of the information presented in the article.
Core Tip: This is a correction to the article titled “Jianpi Gushen Huayu decoction ameliorated diabetic nephropathy through modulating metabolites in kidney, and inhibiting TLR4/NF-κB/NLRP3 and JNK/P38 pathways (World J Diabetes 2024; 15 (3): 502-518 PMID: 38591083 DOI: 10.4239/wjd.v15.i3.502”). Following publication, it was identified that Figure 2 contained an error due to a typesetting issue. As the corresponding author, I am submitting a corrected figure to ensure the accuracy of the information provided in this article. This correction does not impact the conclusions of the manuscript.
